M402 in Combination With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2015 by Momenta Pharmaceuticals, Inc.
Sponsor:
Information provided by (Responsible Party):
Momenta Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT01621243
First received: May 22, 2012
Last updated: March 25, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2017
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)